Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 3,840.00
-30.00 (-0.78%)
At close: Jun 5, 2025, 3:30 PM KST
Prestige Biologics Revenue
Prestige Biologics had revenue of 3.48B KRW in the quarter ending March 31, 2025, with 444.88% growth. This brings the company's revenue in the last twelve months to 6.71B, up 284.40% year-over-year. In the fiscal year ending June 30, 2024, Prestige Biologics had annual revenue of 2.17B with 24.24% growth.
Revenue (ttm)
6.71B
Revenue Growth
+284.40%
P/S Ratio
42.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
282.19B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| Kia Corporation | 109.25T |